Reuters logo
BRIEF-Immunovia announces data exceeding 90 pct accuracy in distinguishing SLE
January 13, 2017 / 8:17 AM / in 9 months

BRIEF-Immunovia announces data exceeding 90 pct accuracy in distinguishing SLE

Jan 13 (Reuters) - Immunovia AB :

* Said on Thursday principal aim of a large retrospective study, performed in collaboration with Lund University’s IDEA Centre, was achieved

* Data confirms that IMMray biomarker signatures can distinguish Systemic Lupus Erythematosus (SLE) from three other main autoimmune diseases, rheumatoid arthritis, Sjögren’s disease and vasculitis with an average accuracy exceeding 90%

Source text for Eikon:

Further company coverage:

Gdynia Newsroom

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below